Similarly, K-Ras signaling in pancreatic cancer activates NF-κB, which results in enhanced miR-155 expression, repressed FOXO3 expression and increased ROS accumulation [66]. This evidence concerns the gene FOXO3 and familial pancreatic carcinoma.